Sustainability Home  > Environmental Performance > Compliance

Environmental Performance: Compliance

The foundation of Bristol-Myers Squibb’s EHS program is to be in compliance with government regulations and worldwide corporate guidelines designed to help protect the environment, our workers, and the public. We continue to show improvement in compliance, although there were times when we failed to fully meet permit or regulatory requirements.

Bristol-Myers Squibb cooperates with local, national, and international regulatory bodies to help develop environmental standards. In many countries, our facilities are recognized as being leaders in EHS performance, and government authorities look to our EHS experts for best practices in EHS management.

Violations and Fines

Bristol-Myers Squibb tracks citations, administrative orders, and similar notifications worldwide as a result of government interactions and inspections. Whenever a facility violates a regulatory requirement, management determines the cause of the noncompliance, takes appropriate corrective measures, and, if necessary, develops an action plan to prevent its recurrence.

There were about 160, 190, and 210 government-initiated interactions in 2004, 2005, and 2006 respectively (including, but not limited to, site visits or inspections) at Bristol-Myers Squibb facilities relating to EHS.

The global reporting information provided below reflects only penalties associated with government inspections and does not include, for example, self-reported permit exceedances or minor administrative errors. Also, fines associated with a violation are assigned to the year the fine was paid.

Recent Citations History

The number of regulatory citations issued to Bristol-Myers Squibb was 27, 43, and 21 in the years 2004, 2005 and 2006, respectively. The total penalties paid by the company with the corresponding number of citations in parenthesis were less than $75,000 (8) in 2004; $25,000 (14) in 2005; and $20,000 (6) in 2006.

For more information on environmental proceedings with a governmental authority that may involve potential monetary sanctions of $100,000 or more (the threshold prescribed by specific SEC rule), a civil action or an environmental claim that could result in significant liabilities, updates of ongoing matters, or the resolution of other matters, disclosed in recent public filings and a summary of remediation costs, see the Environmental Proceedings section of the Notes to Consolidated Statements in the Bristol-Myers Squibb 2006 Annual Report.

back to topReportable Spills

All Bristol-Myers Squibb facilities maintain a spill prevention and response plan to minimize and properly manage any spill or unintended release to the environment. Our long-term goal is to prevent all spills.

back to topInvestigation/Remediation Activities

Bristol-Myers Squibb, like most major industrial companies, is involved in a number of environmental cleanups associated with past activities, even though the activities were lawful and acceptable at the time they occurred. We invest resources to achieve cleanup in a manner that is environmentally and financially responsible. We utilize risk management techniques whenever possible to determine the most effective approaches to pursue at each cleanup site.

Our prevention-based initiatives, such as product life cycle reviews and best practices transfer, will minimize our future involvement in remediation activities.

Through the end of 2006, Bristol-Myers Squibb estimates its share of the total future costs for these sites is approximately $67 million. The company has paid less than $6 million (excluding legal fees) in each of the last five years for investigation and remediation of such matters, including liabilities under CERCLA and other on-site remediation.

Bristol-Myers Squibb’s EHS and legal staff routinely interact with government agencies, and we often pursue cleanups using innovative remedial technologies. We also work very closely with other Potentially Responsible Parties to partner with government agencies and community groups toward the common goal of providing cost-effective remediation that protects human health and the environment.

Investigation/remediation projects were underway at the following Bristol-Myers Squibb operating facilities in 2006:

back to top


Last updated November 9, 2007 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.

 

More on Environmental Performance:

Materials

Energy

Water

Biodiversity

Emissions, Effluents, and Waste

Suppliers

Products and Services

Compliance

Transport

EHS Investments

Regional Environmental Performance Breakdown

About this Report

Company profile

Pledge

Customer Information

Supplier Information

Contractor Information

Student Information

Members of the Community

Benchmarking

Awards

Glossary

Links